BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31692265)

  • 1. Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer.
    Sun J; Piao J; Li N; Yang Y; Kim KY; Lin Z
    FEBS J; 2020 May; 287(10):2118-2133. PubMed ID: 31692265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid attenuates sepsis-induced myocardial dysfunction in rats by accelerating autophagy through the PTEN/AKT/mTOR pathway.
    Shi X; Liu Y; Zhang D; Xiao D
    Life Sci; 2019 Sep; 232():116613. PubMed ID: 31265853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic effects of valproic acid on miR-34a, miR-520h and HDAC1 gene in breast cancer.
    Injinari N; Amini-Farsani Z; Yadollahi-Farsani M; Teimori H
    Life Sci; 2021 Mar; 269():119027. PubMed ID: 33453248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
    Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
    J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line.
    Yagi Y; Fushida S; Harada S; Kinoshita J; Makino I; Oyama K; Tajima H; Fujita H; Takamura H; Ninomiya I; Fujimura T; Ohta T; Yashiro M; Hirakawa K
    J Exp Clin Cancer Res; 2010 Nov; 29(1):149. PubMed ID: 21080974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells.
    Jahani M; Khanahmad H; Nikpour P
    J Gastrointest Cancer; 2021 Jun; 52(2):676-681. PubMed ID: 32621111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma.
    Dong LH; Cheng S; Zheng Z; Wang L; Shen Y; Shen ZX; Chen SJ; Zhao WL
    J Hematol Oncol; 2013 Jul; 6():53. PubMed ID: 23866964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
    Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
    J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
    Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
    Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways.
    Ling Y; Li Y; Zhu R; Qian J; Liu J; Gao W; Meng C; Miao J; Xiong B; Qiu X; Ling C; Dai H; Zhang Y
    J Nat Prod; 2019 Jun; 82(6):1442-1450. PubMed ID: 31120744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1/angiotensin II axis.
    Choi J; Park S; Kwon TK; Sohn SI; Park KM; Kim JI
    Int J Obes (Lond); 2017 Nov; 41(11):1702-1709. PubMed ID: 28720877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid upregulates the expression of the p75NTR/sortilin receptor complex to induce neuronal apoptosis.
    Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
    Apoptosis; 2020 Oct; 25(9-10):697-714. PubMed ID: 32712736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of histone acetylation/deacetylation imbalances on key gene of planar cell polarity pathway].
    Duan HY; Zhang Y; Zhou KY; Wang C; Qiu DJ; Hua YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):475-483. PubMed ID: 28407839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.
    Juengel E; Makarević J; Tsaur I; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
    PLoS One; 2013; 8(1):e53100. PubMed ID: 23372654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance.
    Santoro F; Botrugno OA; Dal Zuffo R; Pallavicini I; Matthews GM; Cluse L; Barozzi I; Senese S; Fornasari L; Moretti S; Altucci L; Pelicci PG; Chiocca S; Johnstone RW; Minucci S
    Blood; 2013 Apr; 121(17):3459-68. PubMed ID: 23440245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis and autophagy in metastatic thyroid cancer cells by valproic acid (VPA).
    Xu Y; Xu D; Zhu SJ; Ye B; Dong JD; Zhang YL; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(7):8291-7. PubMed ID: 26339399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
    Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
    Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.